150 related articles for article (PubMed ID: 12466970)
1. Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer.
Span PN; Manders P; Heuvel JJ; Thomas CM; Bosch RR; Beex LV; Sweep CG
Oncogene; 2002 Dec; 21(55):8506-9. PubMed ID: 12466970
[TBL] [Abstract][Full Text] [Related]
2. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
[TBL] [Abstract][Full Text] [Related]
3. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
Davidson B; Reich R; Goldberg I; Gotlieb WH; Kopolovic J; Berner A; Ben-Baruch G; Bryne M; Nesland JM
Clin Cancer Res; 2001 Mar; 7(3):551-7. PubMed ID: 11297247
[TBL] [Abstract][Full Text] [Related]
4. Angiogenic molecule expression is downregulated in effusions from breast cancer patients.
Konstantinovsky S; Nielsen S; Vyberg M; Kvalheim G; Nesland JM; Reich R; Davidson B
Breast Cancer Res Treat; 2005 Nov; 94(1):71-80. PubMed ID: 16142438
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of Ets-1 overexpression in betel and tobacco related oral cancer.
Pande P; Soni S; Chakravarti N; Mathur M; Shukla NK; Ralhan R
Cancer Detect Prev; 2001; 25(5):496-501. PubMed ID: 11718456
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
Nagai MA; Fregnani JH; Netto MM; Brentani MM; Soares FA
Breast Cancer Res Treat; 2007 Nov; 106(1):49-56. PubMed ID: 17211533
[TBL] [Abstract][Full Text] [Related]
7. Expression of ets-1 transcription factor in human head and neck squamous cell carcinoma and effect of histamine on metastatic potential of invasive tumor through the regulation of expression of ets-1 and matrix metalloproteinase-3.
Horváth B; Hegyesi H; Nagy P; Falus A; Schaff Z
Head Neck; 2005 Jul; 27(7):585-96. PubMed ID: 15887216
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Clin Cancer Res; 2003 Feb; 9(2):716-21. PubMed ID: 12576440
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer.
Jiang WG; Douglas-Jones AG; Mansel RE
Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):125-34. PubMed ID: 16364620
[TBL] [Abstract][Full Text] [Related]
10. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma.
Cheng S; Tada M; Hida Y; Asano T; Kuramae T; Takemoto N; Hamada J; Miyamoto M; Hirano S; Kondo S; Moriuchi T
J Surg Res; 2008 May; 146(1):104-9. PubMed ID: 17663001
[TBL] [Abstract][Full Text] [Related]
11. The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer.
Behrens P; Rothe M; Wellmann A; Krischler J; Wernert N
J Pathol; 2001 May; 194(1):43-50. PubMed ID: 11329140
[TBL] [Abstract][Full Text] [Related]
12. Importance of ets1 proto-oncogene for breast cancer progression.
Dittmer J; Vetter M; Blumenthal SG; Lindemann RK; Kölbl H
Zentralbl Gynakol; 2004 Aug; 126(4):269-71. PubMed ID: 15389378
[TBL] [Abstract][Full Text] [Related]
13. STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell.
Jung HH; Lee J; Kim JH; Ryu KJ; Kang SA; Park C; Sung K; Nam DH; Kang WK; Park K; Im YH
FEBS Lett; 2005 Jul; 579(18):3941-6. PubMed ID: 15996661
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer.
Sasaki H; Yukiue H; Moiriyama S; Kobayashi Y; Nakashima Y; Kaji M; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y
J Surg Res; 2001 Dec; 101(2):242-7. PubMed ID: 11735282
[TBL] [Abstract][Full Text] [Related]
15. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
[TBL] [Abstract][Full Text] [Related]
16. Ets-1 expression in vascular endothelial cells as an angiogenic and prognostic factor in colorectal carcinoma.
Tokuhara K; Ogata Y; Nakagawa M; Shirouzu K
Int Surg; 2003; 88(1):25-33. PubMed ID: 12731728
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
19. ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer.
Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Kawaguchi M; Miura Y; Iwase H
Clin Cancer Res; 2005 Jan; 11(1):193-8. PubMed ID: 15671546
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of Ets-1 and p53 in oral carcinomas is associated with P-glycoprotein expression and poor prognosis.
Soni S; Pande P; Shukla NK; Ralhan R
J Cancer Res Clin Oncol; 2002 Jun; 128(6):336-42. PubMed ID: 12073053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
